The award recognizes MNDR&#39;s proprietary PhiGPT-powered ecosystem, with Aiko as the agentic patient companion redefining responsible, inclusive, and empathetic digital healthcare.Singapore, Singapore--(Newsfile Corp.

<p>The award recognizes MNDR's proprietary PhiGPT-powered ecosystem, with Aiko as the agentic patient companion redefining responsible, inclusive, and empathetic digital healthcare.</p><p>Singapore, Singapore--(Newsfile Corp. - July 22, 2026) - Mobile-health Network Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/MNDR">MNDR</a>) ("MNDR"), an <b>AI-powered intelligent healthcare ecosystem</b>, today announced it has been awarded the <b>2026 Technology for Good Distinction Award</b>, following its recognition in 2025.</p><p>This year's award highlights MNDR's <b>AI Intelligent Healthcare Ecosystem</b>, anchored by <b>Aiko &#8212; the Agentic Patient Companion</b>. Powered by MNDR's proprietary <b>PhiGPT clinical AI engine</b>, Aiko transforms healthcare from episodic transactions into continuous, relationship-based support, offering patients empathetic guidance, preventive nudges, and multilingual access across diverse communities.</p><p><b>Award Highlights</b></p><ul style="list-style-type: disc;"><li><b>Personalised Lifelong Care:</b> Aiko adapts to each patient's age, language, medical history, and care context, evolving into a lifelong health partner.</li><li><b>Preventive Intelligence:</b> From vaccination reminders to lifestyle nudges and daily health alerts, Aiko anticipates patient needs before illness episodes escalate.</li><li><b>Agentic Capabilities:</b> Aiko recommends, connects, monitors, and follows up, linking patients to doctors, services, and Communities of Care.</li><li><b>Privacy-First Design:</b> Embedded in MNDR's closed ecosystem, Aiko ensures patient trust through secure, doctor-led validation and responsible data posture.</li><li><b>Global Inclusion:</b> Multilingual support broadens access for elderly, rural, and underserved populations across Southeast Asia and Sub-Saharan Africa.</li></ul><p><b>Leadership Statement</b></p><p>Dr. Siaw Tung Yeng, Co-CEO of MNDR, stated: <i>"Winning the Technology for Good Award for the second consecutive year underscores our commitment to responsible innovation. Aiko is the embodiment of our AI Intelligent Healthcare Ecosystem &#8212; empathetic, personalised, and trusted &#8212; making quality care accessible across communities."</i></p><p style="text-align: center;"><a rel="nofollow" href="https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001full.jpg"><img src="https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001.jpg" style="border-width: 0px;" alt="Cannot view this image? Visit: https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001.jpg" /></a></p><p style="text-align: center;">From left to right, Dr. Choo Pei Ling (&#26417;&#20329;&#29618;), Dr. Siaw, Dr. Teoh, Alan Ng<br /><br />To view an enhanced version of this graphic, please visit:<br /><a rel="nofollow" href="https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001full.jpg">https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001full.jpg</a></p><p><b>About Mobile-health Network Solutions</b></p><p>Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.</p><p><b>Forward-Looking Statements</b></p><p>Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.</p><div id="contactInfo"><p><b>For media inquiries, please contact:</b></p><p><b>Mobile-health Network Solutions Investor Relations Contact:</b></p><p>2 Venture Drive, #07-08 Vision Exchange<br />Singapore 608526<br />(+65) 6222 5223<br />Email: <a href="mailto:investors@manadr.com">investors@manadr.com</a></p><p><b>Investor Relations Inquiries:</b></p><p>Skyline Corporate Communications Group, LLC<br />Scott Powell, President<br />1177 Avenue of the Americas, 5<sup>th</sup> Floor<br />New York, New York 10036<br />Office: (646) 893-5835<br />Email: <a href="mailto:ir@skylineccg.com">ir@skylineccg.com</a></p></div><p id="corporateNewsLogoContainer"><img src="https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_logo.jpg" id="corporateNewsLogo" alt="Corporate Logo" /></p><p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://api.newsfilecorp.com/redirect/mjXGAH4yRp">https://www.newsfilecorp.com/release/306081</a></p><p><img src="https://api.newsfilecorp.com/newsinfo/306081/197" alt="" /></p>

MNDR

MNDR Wins 2026 Technology for Good Award, Featuring Aiko in Its AI Intelligent Healthcare Ecosystem

MNDR Wins 2026 Technology for Good Award, Validating AI Healthcare Platform

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>The award recognizes MNDR&amp;#39;s proprietary PhiGPT-powered ecosystem, with Aiko as the agentic patient companion redefining responsible, inclusive, and empathetic digital healthcare.Singapore, Singapore--(Newsfile Corp.</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>MNDR announced it earned the 2026 Technology for Good Distinction Award for its PhiGPT-powered AI healthcare ecosystem, led by Aiko. The accolade emphasizes continuous, relationship-based care, multilingual access, and privacy-first design, which could accelerate partnerships and US market entry. This recognition strengthens MNDR&#039;s growth narrative and potential monetization trajectory.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>MNDR wins the 2026 Technology for Good Distinction Award for its PhiGPT ecosystem.</li><li>Aiko Agentic Patient Companion enables continuous, multilingual, preventive care.</li><li>Privacy-first design and global inclusion expand access.</li><li>US expansion plans could drive future growth and partnerships.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Mobile-health Network Solutions (MNDR)</strong>: NASDAQ-listed; award reinforces the company’s AI healthcare ecosystem and potential partnerships.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments; aligns with industry-wide interest in AI-enabled healthcare and recognition that can influence partnerships, investor sentiment, and valuation.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Award validation may lift near-term investor sentiment and trading tone for MNDR.</li><li>Aiko-driven preventive, multilingual care reinforces scalable monetization potential.</li><li>Plans for US expansion could unlock new partnerships and revenue streams.</li><li>Forward-looking statements risk could cap immediate upside.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Date of release: July 22, 2026.</li><li>Award: 2026 Technology for Good Distinction Award.</li><li>Recognition previously received in 2025.</li><li>Product: PhiGPT clinical AI engine powering Aiko.</li><li>Global scope includes Southeast Asia and Sub-Saharan Africa; expansion to the US planned.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Positive short-term sentiment; longer-term upside depends on successful US expansion and monetization.</p>
  </section>
</section>


<p>The award recognizes MNDR's proprietary PhiGPT-powered ecosystem, with Aiko as the agentic patient companion redefining responsible, inclusive, and empathetic digital healthcare.</p><p>Singapore, Singapore--(Newsfile Corp. - July 22, 2026) - Mobile-health Network Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/MNDR">MNDR</a>) ("MNDR"), an <b>AI-powered intelligent healthcare ecosystem</b>, today announced it has been awarded the <b>2026 Technology for Good Distinction Award</b>, following its recognition in 2025.</p><p>This year's award highlights MNDR's <b>AI Intelligent Healthcare Ecosystem</b>, anchored by <b>Aiko &#8212; the Agentic Patient Companion</b>. Powered by MNDR's proprietary <b>PhiGPT clinical AI engine</b>, Aiko transforms healthcare from episodic transactions into continuous, relationship-based support, offering patients empathetic guidance, preventive nudges, and multilingual access across diverse communities.</p><p><b>Award Highlights</b></p><ul style="list-style-type: disc;"><li><b>Personalised Lifelong Care:</b> Aiko adapts to each patient's age, language, medical history, and care context, evolving into a lifelong health partner.</li><li><b>Preventive Intelligence:</b> From vaccination reminders to lifestyle nudges and daily health alerts, Aiko anticipates patient needs before illness episodes escalate.</li><li><b>Agentic Capabilities:</b> Aiko recommends, connects, monitors, and follows up, linking patients to doctors, services, and Communities of Care.</li><li><b>Privacy-First Design:</b> Embedded in MNDR's closed ecosystem, Aiko ensures patient trust through secure, doctor-led validation and responsible data posture.</li><li><b>Global Inclusion:</b> Multilingual support broadens access for elderly, rural, and underserved populations across Southeast Asia and Sub-Saharan Africa.</li></ul><p><b>Leadership Statement</b></p><p>Dr. Siaw Tung Yeng, Co-CEO of MNDR, stated: <i>"Winning the Technology for Good Award for the second consecutive year underscores our commitment to responsible innovation. Aiko is the embodiment of our AI Intelligent Healthcare Ecosystem &#8212; empathetic, personalised, and trusted &#8212; making quality care accessible across communities."</i></p><p style="text-align: center;"><a rel="nofollow" href="https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001full.jpg"><img src="https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001.jpg" style="border-width: 0px;" alt="Cannot view this image? Visit: https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001.jpg" /></a></p><p style="text-align: center;">From left to right, Dr. Choo Pei Ling (&#26417;&#20329;&#29618;), Dr. Siaw, Dr. Teoh, Alan Ng<br /><br />To view an enhanced version of this graphic, please visit:<br /><a rel="nofollow" href="https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001full.jpg">https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_001full.jpg</a></p><p><b>About Mobile-health Network Solutions</b></p><p>Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.</p><p><b>Forward-Looking Statements</b></p><p>Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.</p><div id="contactInfo"><p><b>For media inquiries, please contact:</b></p><p><b>Mobile-health Network Solutions Investor Relations Contact:</b></p><p>2 Venture Drive, #07-08 Vision Exchange<br />Singapore 608526<br />(+65) 6222 5223<br />Email: <a href="mailto:investors@manadr.com">investors@manadr.com</a></p><p><b>Investor Relations Inquiries:</b></p><p>Skyline Corporate Communications Group, LLC<br />Scott Powell, President<br />1177 Avenue of the Americas, 5<sup>th</sup> Floor<br />New York, New York 10036<br />Office: (646) 893-5835<br />Email: <a href="mailto:ir@skylineccg.com">ir@skylineccg.com</a></p></div><p id="corporateNewsLogoContainer"><img src="https://images.newsfilecorp.com/files/10584/306081_792255ad54661a87_logo.jpg" id="corporateNewsLogo" alt="Corporate Logo" /></p><p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://api.newsfilecorp.com/redirect/mjXGAH4yRp">https://www.newsfilecorp.com/release/306081</a></p><p><img src="https://api.newsfilecorp.com/newsinfo/306081/197" alt="" /></p>

MNDR announced it earned the 2026 Technology for Good Distinction Award for its PhiGPT-powered AI healthcare ecosystem, led by Aiko. The accolade emphasizes continuous, relationship-based care, multilingual access, and privacy-first design, which could accelerate partnerships and US market entry. This recognition strengthens MNDR's growth narrative and potential monetization trajectory.

News insight

MNDR Wins 2026 Technology for Good Award, Featuring Aiko in Its AI Intelligent Healthcare Ecosystem

AI summary

Sentiment rationale

Key facts

Corporate Developments